Company Imeik Technology Development Co.,Ltd.

Equities

300896

CNE100004868

Medical Equipment, Supplies & Distribution

Analysts' Consensus

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per Business

Ratings for Imeik Technology Development Co.,Ltd.

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Medical Devices & Implants

End-of-day quote Shenzhen S.E. Other stock markets 06:00:00 2024-04-24 pm EDT			5-day change	1st Jan Change
293.2 ^CNY	+1.85%		+0.75%	-0.39%

Apr. 24	Imeik Technology Development Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Mar. 20	Imeik Technology Development's Profit Rises 47% on Higher Revenue	MT

Imeik Technology Development Co Ltd is a China-based company mainly engaged in the research and development, production and sales of biomedical materials. The Company focuses on the development and transformation of biomedical materials, and is committed to the development of biomedicine such as recombinant proteins and peptides. The Company has realized the industrialization of injection-type sodium hyaluronate series products and polydioxanone facial implants, and has established a product technology transformation platform for biomedical materials such as medical chitosan and polylactic acid. The Company's self-developed products are mainly aimed at the repair of fold skin on the face and neck. The clinical applications of its products cover medical cosmetology, surgical repair, and treatment of metabolic diseases. The Company mainly conducts its businesses in the China market.

Number of employees: 910

CNY in Million	2022	Weight	2023	Weight	Delta
Solution Injection 58.2 %	1,293	66.7 %	1,671	58.2 %	+29.22%
Gel Injection 40.3 %	638	32.9 %	1,158	40.3 %	+81.43%
Others 1.2 %	3	0.1 %	35	1.2 %	+1,265.80%
Facial Implants 0.2 %	5	0.3 %	6	0.2 %	+10.06%

CNY in Million	2022	Weight	2023	Weight	Delta
China 100.0 %	1,939	100.0 %	2,869	100.0 %	+47.99%

Managers	Title	Age	Since
Yi Feng Shi CEO	Chief Executive Officer	50	09-12-31
Ren Chao Zhang DFI	Director of Finance/CFO	46	21-10-31
Rui Rui Feng		44	-
Yong Jian BRD	Director/Board Member	56	98-12-31
Qiao Qian Ma IRC	Investor Relations Contact	-	-
Li Na Gou SAM	Sales & Marketing	42	09-12-31
Yong Lei Yin PRN	Corporate Officer/Principal	42	07-08-31

Members of the board	Title	Age	Since
Zhong Chen CHM	Chairman	68	22-11-16
Yu Qun Yu BRD	Director/Board Member	59	21-07-11
Da Qi Zhu BRD	Director/Board Member	57	22-11-16
Xin Yang Lin BRD	Director/Board Member	59	16-10-31
Gang Chen BRD	Director/Board Member	60	22-11-16
Jun Jian CHM	Chairman	61	04-05-31
Yi Feng Shi CEO	Chief Executive Officer	50	09-12-31
Lan Zhu Wang BRD	Director/Board Member	60	10-12-31
Yong Jian BRD	Director/Board Member	56	98-12-31
Ren Chao Zhang DFI	Director of Finance/CFO	46	21-10-31

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	216,360,000	76,349,960 ( 35.29 %)	1,165,874 ( 0.5389 %)	35.29 %

Name	Equities	%	Valuation
Jun Jian 30.96 %	66,988,343	30.96 %	3 202 M ¥
Xiamen Zhixin Junxing Investment Management Partnership LP 6.414 %	13,877,244	6.414 %	663 M ¥
Xiamen Danrui Investment Management Partnership LP 4.846 %	10,485,029	4.846 %	501 M ¥
Xiamen Kezhishang Investment Partnership LP 4.276 %	9,251,496	4.276 %	442 M ¥
Jiaxing Jifeng Equity Investment Management Co. Ltd. 3.264 %	7,062,200	3.264 %	338 M ¥
Feng Yuan 3.244 %	7,018,491	3.244 %	335 M ¥
Yong Jian 2.423 %	5,242,514	2.423 %	251 M ¥
Bank of Communications Schroder Fund Management Co., Ltd. 1.785 %	3,862,493	1.785 %	185 M ¥
Zheng Pu Zhang 1.348 %	2,917,115	1.348 %	139 M ¥
Hwabao WP Fund Management Co., Ltd. 1.326 %	2,868,910	1.326 %	137 M ¥

Name	Equities	%	Valuation
Yi Feng Shi 6.288 %	7,863,772	6.288 %	376 M ¥
Lan Zhu Wang 3.948 %	4,937,604	3.948 %	236 M ¥
Zheng Pu Zhang 2.333 %	2,917,115	2.333 %	139 M ¥

Imeik Technology Development Co., Ltd.

21/F, Tower C, Shimao Building 92 Jianguo Road A

100022, Beijing

http://www.imeik.com

address Imeik Technology Development Co.,Ltd.(300896)

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

293.2 CNY

Average target price

442.3 CNY

Spread / Average Target

+50.87%

Consensus

Estimates Revisions

Company calendar

Healthcare

Healthcare Services

Healthcare Equipment & Supplies

Medical Equipment, Supplies & Distribution

Medical Devices & Implants

	1st Jan change	Capi.
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD.	-0.39%	8.71B
STRYKER CORPORATION	+12.59%	128B
SMITH & NEPHEW PLC	-10.58%	10.51B
INSPIRE MEDICAL SYSTEMS, INC.	+13.56%	7B
GLAUKOS CORPORATION	+25.94%	5.02B
AXONICS, INC.	+6.93%	3.39B
ENOVIS CORPORATION	-1.64%	3.02B
BEIJING BALANCE MEDICAL TECHNOLOGY CO.,LTD.	-11.96%	2.07B
SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD.	-7.25%	2.06B
DOUBLE MEDICAL TECHNOLOGY INC.	-25.23%	1.73B

Medical Devices & Implants